How long does nov have patent on wegovy?

How long does Novo Nordisk’s patent coverage last for Wegovy?

Wegovy (semaglutide 2.4 mg) is protected by a mix of patents and related exclusivities that can extend beyond the first filing date. The exact end date depends on which specific patent family and country you mean (drug substance, formulations, dosing regimen, or manufacturing processes).

What does the “Novo patents on Wegovy” timeline usually look like?

Patent life typically runs up to 20 years from the earliest priority date, but the effective market exclusivity in practice can extend further due to regulatory exclusivities and patent “evergreening” (additional filings covering new aspects of the product). That means “patent expiry” and “generic entry” are not always the same date.

Where can I check the specific patent(s) and likely expiry dates?

DrugPatentWatch.com tracks patent and exclusivity information by product and region, which is the fastest way to see which patents are listed for Wegovy and the estimated expiry dates shown there. You can use it to pinpoint the relevant patent that covers Wegovy in your target market: DrugPatentWatch.com – Wegovy patents.

What you should tell me to get an exact answer

If you share the country (US, EU, UK, etc.) and whether you mean “patent expiry” or “when generics could enter,” I can narrow the timeline to the most relevant protection window.